Kliniske studier Effekten og sikkerheden af lenalidomid blev vurderet i to randomiserede, dobbeltblinde, placebo - og parallel- gruppe- kontrollerede, multicenter, fase III- studier (MM- 009 og MM- 010).
Clinical trials The efficacy and safety of lenalidomide were evaluated in two Phase III multi-centre, randomised, double-blind, placebo-controlled, parallel-group controlled studies (MM-009 and MM-010) of